100 related articles for article (PubMed ID: 12204622)
1. The self-association of the drug acemetacin and its interactions and stabilization with beta-cyclodextrin in aqueous solution as inferred from NMR spectroscopy and HPLC studies.
Zouvelekis D; Yannakopoulou K; Mavridis IM; Antoniadou-Vyza E
Carbohydr Res; 2002 Sep; 337(15):1387-95. PubMed ID: 12204622
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of solution state complexation in wet-granulated oven-dried ibuprofen and beta-cyclodextrin: FT-IR and 1H-NMR studies.
Ghorab MK; Adeyeye MC
Pharm Dev Technol; 2001 Aug; 6(3):315-24. PubMed ID: 11485173
[TBL] [Abstract][Full Text] [Related]
3. The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity.
Salústio PJ; Feio G; Figueirinhas JL; Pinto JF; Cabral Marques HM
Eur J Pharm Biopharm; 2009 Feb; 71(2):377-86. PubMed ID: 18977436
[TBL] [Abstract][Full Text] [Related]
4. Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-beta-cyclodextrin solution.
Iohara D; Hirayama F; Ishiguro T; Arima H; Uekama K
Int J Pharm; 2008 Apr; 354(1-2):70-6. PubMed ID: 18093762
[TBL] [Abstract][Full Text] [Related]
5. Acemetacin monohydrate.
Gelbrich T; Haddow MF; Griesser UJ
Acta Crystallogr C; 2007 Aug; 63(Pt 8):o451-3. PubMed ID: 17675694
[TBL] [Abstract][Full Text] [Related]
6. Complexation study of diclofenac with beta-cyclodextrin and spectrofluorimetric determination.
Arancibia JA; Escandar GM
Analyst; 1999 Dec; 124(12):1833-8. PubMed ID: 10746311
[TBL] [Abstract][Full Text] [Related]
7. Effect of cyclodextrin derivatives on indomethacin stability in aqueous solution.
Backensfeld T; Müller BW; Wiese M; Seydel JK
Pharm Res; 1990 May; 7(5):484-90. PubMed ID: 2367316
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical and biological properties of 6(1),6(3),6(5)-tri-O-alpha-maltosyl-cyclomaltoheptaose (6(1),6(3),6(5)-tri-O-alpha-maltosyl-beta-cyclodextrin).
Okada Y; Semma M; Ichikawa A
Carbohydr Res; 2007 Jul; 342(10):1315-22. PubMed ID: 17498674
[TBL] [Abstract][Full Text] [Related]
9. Molecular structures of the inclusion complexes beta-cyclodextrin-1,2-bis(4-aminophenyl)ethane and beta-cyclodextrin-4,4'-diaminobiphenyl; packing of dimeric beta-cyclodextrin inclusion complexes.
Giastas P; Yannakopoulou K; Mavridis IM
Acta Crystallogr B; 2003 Apr; 59(Pt 2):287-99. PubMed ID: 12657820
[TBL] [Abstract][Full Text] [Related]
10. Raman and solid state 13C-NMR investigation of the structure of the 1 : 1 amorphous piroxicam : beta-cyclodextrin inclusion compound.
Redenti E; Zanol M; Ventura P; Fronza G; Comotti A; Taddei P; Bertoluzza A
Biospectroscopy; 1999; 5(4):243-51. PubMed ID: 10478955
[TBL] [Abstract][Full Text] [Related]
11. Interaction of p-hydroxybenzoic esters with beta-cyclodextrin.
Chan LW; Kurup TR; Muthaiah A; Thenmozhiyal JC
Int J Pharm; 2000 Feb; 195(1-2):71-9. PubMed ID: 10675685
[TBL] [Abstract][Full Text] [Related]
12. Multimodal inclusion complexes between barbiturates and 2-hydroxypropyl-beta-cyclodextrin in aqueous solution: isothermal titration microcalorimetry, (13)C NMR spectrometry, and molecular dynamics simulation.
Aki H; Niiya T; Iwase Y; Yamamoto M
J Pharm Sci; 2001 Aug; 90(8):1186-97. PubMed ID: 11536223
[TBL] [Abstract][Full Text] [Related]
13. Effect of cyclodextrin additives on azithromycin in aqueous solution and insight into the stabilization mechanism by sulfobutyl ether-β-cyclodextrin.
Saita MG; Aleo D; Melilli B; Patti A
Int J Pharm; 2019 Jul; 566():674-679. PubMed ID: 31202899
[TBL] [Abstract][Full Text] [Related]
14. A 1H NMR Study of Host/Guest Supramolecular Complexes of a Curcumin Analogue with β-Cyclodextrin and a β-Cyclodextrin-Conjugated Gemini Surfactant.
Poorghorban M; Karoyo AH; Grochulski P; Verrall RE; Wilson LD; Badea I
Mol Pharm; 2015 Aug; 12(8):2993-3006. PubMed ID: 26083126
[TBL] [Abstract][Full Text] [Related]
15. Influence of cyclodextrins on the stability of the peptide salmon calcitonin in aqueous solution.
Sigurjónsdóttir JF; Loftsson T; Másson M
Int J Pharm; 1999 Sep; 186(2):205-13. PubMed ID: 10486439
[TBL] [Abstract][Full Text] [Related]
16. Inclusion complexes of nabumetone with beta-cyclodextrins: thermodynamics and molecular modelling studies. Influence of sodium perchlorate.
Goyenechea N; Sánchez M; Vélaz I; Martín C; Martínez-Ohárriz MC; González-Gaitano G
Luminescence; 2001; 16(2):117-27. PubMed ID: 11312537
[TBL] [Abstract][Full Text] [Related]
17. Formulation of indomethacin eye drops via complexation with cyclodextrins.
Halim Mohamed MA; Mahmoud AA
Curr Eye Res; 2011 Mar; 36(3):208-16. PubMed ID: 21275515
[TBL] [Abstract][Full Text] [Related]
18. Binding of sodium salicylate by beta-cyclodextrin or 2,6-di-O-methyl-beta-cyclodextrin in aqueous solution.
Junquera E; Peña L; Aicart E
J Pharm Sci; 1998 Jan; 87(1):86-90. PubMed ID: 9452974
[TBL] [Abstract][Full Text] [Related]
19. [On the pharmacodynamics of acemetacin (author's transl)].
Jacobi H; Dell HD
Arzneimittelforschung; 1980; 30(8A):1348-62. PubMed ID: 6968219
[TBL] [Abstract][Full Text] [Related]
20. Melarsoprol-cyclodextrins inclusion complexes.
Gibaud S; Zirar SB; Mutzenhardt P; Fries I; Astier A
Int J Pharm; 2005 Dec; 306(1-2):107-21. PubMed ID: 16253447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
